NervGen Reports Third Quarter 2026 Financial Results and Provides Business Updates
MIAMI, Nov. 16, 2026 (GLOBE NEWSWIRE) — NervGen (NASDAQ: NGEN), a late-stage clinical biopharmaceutical company developing first-in-class neuroreparative…
MIAMI, Nov. 16, 2026 (GLOBE NEWSWIRE) — NervGen (NASDAQ: NGEN), a late-stage clinical biopharmaceutical company developing first-in-class neuroreparative…
Breakthrough Therapy designation granted based on FDA’s review of safety and efficacy data from the chronic cohort of the Phase 1b/2a CONNECT SCI study.
Proceeds will fund completion of the Phase 1 trial and continued development of C-1101, a potential first-in-class disease-modifying therapeutic -- Clinical data expected in 1H 202...
Axonics Anonymous (not verified) Mon, 11/16/2026 - 00:40 field_thread_url https://cafepharma.com/boards/threads/axonics.704805/ board na...
Axogen’s 26% sales jump is great, but will acquiring BioCircuit make it even higher?
~ Submission to the UK MHRA for review marks critical step towards initiating a Phase 2 Study with CY200 ~
Aspen Neuroscience is looking to join the Nasdaq and raise more money to support its lead program, which aims to turn a patient's own cells into dopamine-producing neurons.
Cerevance plans to meet with the FDA to “determine next steps” for a new kind of medicine known as solengepras, now that it has Phase 3 data in hand.
Appointment follows 12-month interim tenure of scientific, regulatory and commercial achievements for Phase 3 trial preparation in ALS PALO ALTO, Calif., Nov. 13, 2026 /PRNewswire-...
Geron Anonymous (not verified) Wed, 10/28/2026 - 16:21 field_thread_url https://cafepharma.com/boards/threads/geron.694511/ board name...
Capitalizing on a Global Hair Restoration Market Projected to Exceed $23 Billion, the Venture Integrates Advanced Exosome Delivery to Eliminate Microneedling and Reactivate Follicl...
Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the publication of a milestone study.
1,000,000,000 Billion Dollar Nemluvio Goal Anonymous (not verified) Mon, 10/05/2026 - 04:07 field_thread_url https://cafepharma.com/boards/threads/1-000-0...
A small-molecule therapy, VG-3927, targeting microglial TREM2 signaling showed neuroprotective effects in preclinical studies for Alzheimer's disease and was well tolerated in a Ph...
1,000,000,000 Billion Dollar Nemluvio Goal Anonymous (not verified) Tue, 10/06/2026 - 04:08 field_thread_url https://cafepharma.com/boards/threads/1-000-0...
Vera Therapeutics Anonymous (not verified) Mon, 11/16/2026 - 00:40 field_thread_url https://cafepharma.com/boards/threads/vera-therapeutics.713115/...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.